Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-18

Clinical Trial Update: A 2-Part Single Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for E2006 assessing safety, tolerability, PK, and PD in insomnia; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • E2006

Snippet

Sponsor: Eisai Inc. | Conditions: Insomnia | Phase 1 | Status: COMPLETED | Results posted: 2020-01-18